Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2014 2
2015 1
2016 2
2017 2
2018 4
2019 4
2020 6
2021 3
2022 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapy for older patients with melanoma: From darkness to light?
Iacono D, Vitale MG, Basile D, Pelizzari G, Cinausero M, Poletto E, Pascoletti G, Minisini AM. Iacono D, et al. Among authors: poletto e. Pigment Cell Melanoma Res. 2021 May;34(3):550-563. doi: 10.1111/pcmr.12917. Epub 2020 Aug 18. Pigment Cell Melanoma Res. 2021. PMID: 32745351 Review.
CUP-syndrome: Inguinal high grade serous ovarian carcinoma lymph node metastases with unknown primary origin - a case report and literature review.
Restaino S, Mauro J, Zermano S, Pellecchia G, Mariuzzi L, Orsaria M, Titone F, Biasioli A, Della Martina M, Andreetta C, Poletto E, Arcieri M, Buda A, Driul L, Vizzielli G. Restaino S, et al. Among authors: poletto e. Front Oncol. 2022 Oct 10;12:987169. doi: 10.3389/fonc.2022.987169. eCollection 2022. Front Oncol. 2022. PMID: 36300091 Free PMC article. Review.
Mesonephric-Like Adenocarcinomas a Rare Tumor: The Importance of Diagnosis.
Restaino S, Pellecchia G, Tulisso A, Paglietti C, Orsaria M, Andreetta C, Poletto E, Arcieri M, Martina MD, Biasioli A, Mariuzzi L, Driul L, Scambia G, Vizzielli G. Restaino S, et al. Among authors: poletto e. Int J Environ Res Public Health. 2022 Nov 4;19(21):14451. doi: 10.3390/ijerph192114451. Int J Environ Res Public Health. 2022. PMID: 36361332 Free PMC article.
Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?
Bortot L, Targato G, Noto C, Giavarra M, Palmero L, Zara D, Bertoli E, Dri A, Andreetta C, Pascoletti G, Poletto E, Russo S, Seriau L, Mansutti M, Cedolini C, Basile D, Fasola G, Bonotto M, Minisini AM. Bortot L, et al. Among authors: poletto e. Front Oncol. 2022 Jun 7;12:885992. doi: 10.3389/fonc.2022.885992. eCollection 2022. Front Oncol. 2022. PMID: 35747814 Free PMC article.
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study.
La Verde N, Damia G, Garrone O, Santini D, Fabi A, Ciccarese M, Generali DG, Nunzi M, Poletto E, Ferraris E, Cretella E, Scandurra G, Meattini I, Bertolini AS, Cavanna L, Collovà E, Romagnoli E, Rulli E, Legramandi L, Guffanti F, Bramati A, Moretti A, Cassano A, Vici P, Torri V, Farina G; PAINTER investigators. La Verde N, et al. Among authors: poletto e. Breast Cancer Res. 2022 Oct 28;24(1):71. doi: 10.1186/s13058-022-01560-w. Breast Cancer Res. 2022. PMID: 36307826 Free PMC article. Clinical Trial.
28 results